| Line item | შპს პანაცეა | შპს ფიფ კო. ლტდ | შპს კინველ ჯორჯია | შპს ელკადენტ | სს ჰუმანითი ჯორჯია |
|---|---|---|---|---|---|
| Total Revenue | 3,615 | 3,614 | 3,599 | 3,576 | — |
| Total COGS | -2,134 | -2,604 | -3,185 | -2,267 | — |
| Gross Profit | 1,481 | 1,011 | 414 | 1,310 | — |
| Gross Margin | 41.0% | 28.0% | 11.5% | 36.6% | — |
| Total Operating Expenses | -1,317 | -979 | -419 | -11 | — |
| EBITDA | 165 | 32 | -5 | 1,298 | — |
| EBITDA Margin | 4.6% | 0.9% | -0.1% | 36.3% | — |
| Total D&A | -99 | -2 | -5 | 0 | — |
| EBIT / Operating Income | 65 | 30 | -10 | 1,298 | — |
| Total Interest Expense | -20 | — | — | — | — |
| Total Other Income | 134 | -43 | — | 237 | — |
| Profit Before Tax | 179 | -13 | -10 | 1,536 | — |
| Total Income Tax | 0 | -0 | 0 | -128 | — |
| Net Profit / (Loss) | 179 | -13 | -10 | 1,147 | — |
| Net Margin | 5.0% | -0.4% | -0.3% | 32.1% | — |
Not every picked company reports every selected year — FY2024: no filing for სს ჰუმანითი ჯორჯია. Those cells are left blank (no filing), not zero.
| Company | Sector | EBITDA margin · FY 2024 | Percentile | Sector n |
|---|---|---|---|---|
| შპს ელკადენტ | Medical Devices | 36.3% | 97th pct | 35 |
| შპს პანაცეა | Pharma | 4.6% | 20th pct | 103 |
| შპს კინველ ჯორჯია | FMCG | -0.1% | 19th pct | 532 |
| შპს ფიფ კო. ლტდ | Pharma | 0.9% | 17th pct | 103 |
| სს ჰუმანითი ჯორჯია | Pharma | — | no FY data | 103 |
Percentile is within each company's own sector across the whole FY2024 cross-section (1st–100th; higher = larger value). Companies with no sector, or no filing for the year, are not ranked.